The Workshop Report is available by clicking the button below:
Workshop program including a welcome letter from GBSI President Leonard Freedman, detailed agenda, and speaker bios.
Watch the Press Briefing
Asilomar Press Briefing
The audio is muted for the first 30 seconds or so, so please keep listening until it starts. We are editing it and will update.
- Creating antibody standards: Establishing standards and validation techniques for biochemical and cell-based assays using antibody-based applications and methodologies
- Responsibilities of the companies: Engaging antibody suppliers to produce higher-quality, internally validated antibodies
- Drivers for Adoption: Ensuring that validation standards are accepted and practiced by the research community, in part through training and certification
- The Future of Antibodies: Integrating new technologies, including greater investment in recombinant antibodies
Pre-workshop online discussions
Prior to the workshop GBSI hosted antibody validation online discussions. These discussions were designed to engage with the scientific community to build consensus for research antibody validation. The resulting consensus-building documents from these online discussion groups informed the Antibody Validation: Standards, Policies, and Practices workshop.
Consensus Building Documents
Post workshop, we have opened a new thread on protocols.io to continue to continue the discussion on antibody standards—both developing them and gaining widespread community acceptance of them. We value your input. Please return frequently to the discussion to add your perspective as other comment and encourage your colleagues to join in.
Many thanks to our Sponsors
Resources & Articles
We appreciate the support from NIH
Funding for this conference was made possible in part by an National Institutes of Health R-13 grant, GM 121024-01/G236SH. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Workshop Steering Committee
Chair: Leonard P. Freedman, PhD, GBSI
Andrew R. M. Bradbury, MBBS, PhD, Los Alamos National Laboratory
Joshua LaBaer, MD, PhD, Arizona State University
Andreas Plückthun, PhD, University of Zurich
Janice Reichert, PhD, mAbs, The Antibody Society
David Rimm, M.D., Ph.D., Yale University
Mathias Uhlén, PhD, Royal Institute of Technology (KTH), Stockholm
The keynote speech was given on Sunday, September 25 by David McAdams, PhD, Fuqua School of Business and Economics Department, Duke University. Video of the speech will be available soon.
Videos from the Event